Itrabond 200mg 7 Capsules

Babies: Not applicable. Lactating mother: Itrabond capsule is not safe to use during breastfeeding.
Limited human studies have shown that this drug may pass into breastmilk and harm the baby. Pregnancy: It is not safe to use this medication during pregnancy because this drug may cause harmful effects on the developing baby.
Consult your doctor. Alcohol: Caution is advised while consuming alcohol with an itrabond capsule.
Consult your doctor. Driving: Itrabond capsule may cause blurred vision, dizziness, or hearing loss.
Do not drive if these symptoms occur because it may affect your ability to drive. Kidney: Consult your doctor before using this medication in patients with kidney disease.
Liver: Consult your doctor before using this medication in patients with liver disease. Inform your doctor if you notice yellowing of eyes, & skin, and dark-coloured stools.
.

Nausea Common cold Cough Blurred vision Menstrual disorder.

Itrabond works by destroying fungal cell membrane and stops the growth of fungi on your skin. .

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Itrabond capsule is used in the treatment of fungal infections of the mouth, throat, vagina, and other parts of the body like fingernails and toenails. • You have to take the complete course of medication even if you feel better. • It can be taken with food, but at a fixed time daily. • You must use contraceptives methods to avoid pregnancy while taking this medication. • Antacids should be taken after 2 hours while taking this medication. • Advise the patient to go for regular monitoring of liver function tests. • Consult your doctor if you are experienced with allergic reactions, nerve pain, or hearing loss. • Consult your doctor if you notice yellowing of your eyes, skin, dark urine, or stomach pain..

Contraindicated: • Itrabond + Alfuzosin: Concurrent use may result in an increased alfuzosin exposure • Itrabond + Cisapride: Concurrent use may result in increased plasma concentrations of cisapride • Itrabond + Fluconazole: Concurrent use may result in an increased risk of qt-interval prolongation • Itrabond + Lovastatin: Concurrent use may result in an increased risk of myopathy or rhabdomyolysis • Itrabond + Tolvaptan: Concurrent use may result in increased tolvaptan plasma concentrations. Major: • Itrabond + Amiodarone: Concurrent use may result in an increased risk of qt prolongation • Itrabond + Aprepitant: Concurrent use may result in increased plasma concentrations of aprepitant • Itrabond + Citalopram: Concurrent use may result in increased citalopram exposure and risk of qt interval prolongation • Itrabond + Clozapine: Concurrent use may result in increased clozapine exposure and risk of qt interval prolongation • Itrabond + Cyclosporine: Concurrent use may result in an increased risk of cyclosporine toxicity.